Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2024-09-27 Purchase | 2024-09-30 7:12 pm | Viridian Therapeutics Inc. | VRDN | Beetham Thomas W. Chief Operating Officer | 5,000 | $23.41 | $117,050 | 6,000 (Direct) | View |
| 2021-09-16 Sale | 2021-09-20 5:00 pm | Magenta Therapeutics Inc. | MGTA | Beetham Thomas W. See Remarks | 6,103 | $6.73 | $41,073 | 13,897 (Direct) | View |
| 2021-02-03 Sale | 2021-02-05 6:55 pm | Kiniksa Pharmaceuticals Ltd. | KNSA | Beetham Thomas W. EVP & Chief Legal Officer | 2,477 | $22.09 | $54,717 | 411,680 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2025-03-03 Option Award | 2025-03-04 9:13 pm | N/A 2035-03-03 | Viridian Therapeutics Inc. | VRDN | Beetham Thomas W. Chief Operating Officer | 263,450 | $0 | 263,450 (Direct) | View |
| 2023-10-30 Option Award | 2023-11-01 4:35 pm | N/A 2023-10-30 | Viridian Therapeutics Inc. | VRDN | Beetham Thomas W. Chief Operating Officer | 474,400 | $0 | 474,400 (Direct) | View |
| 2022-11-30 Option Award | 2022-12-02 4:26 pm | N/A N/A | Magenta Therapeutics Inc. | MGTA | Beetham Thomas W. See Remarks | 3,000 | $0.94 | 19,897 (Direct) | View |
| 2022-08-01 Option Award | 2022-08-01 9:14 pm | N/A 2032-07-31 | Magenta Therapeutics Inc. | MGTA | Beetham Thomas W. See Remarks | 75,000 | $0 | 75,000 (Direct) | View |
| 2022-05-31 Option Award | 2022-06-06 4:05 pm | N/A N/A | Magenta Therapeutics Inc. | MGTA | Beetham Thomas W. See Remarks | 3,000 | $0.99 | 16,897 (Direct) | View |
| 2022-05-17 Option Award | 2022-05-19 4:18 pm | N/A 2032-05-16 | Magenta Therapeutics Inc. | MGTA | Beetham Thomas W. See Remarks | 50,000 | $0 | 50,000 (Direct) | View |
| 2022-02-15 Option Award | 2022-02-17 5:15 pm | N/A 2032-02-14 | Magenta Therapeutics Inc. | MGTA | Beetham Thomas W. See Remarks | 75,000 | $0 | 75,000 (Direct) | View |
| 2021-09-14 Option Award | 2021-09-16 7:39 pm | N/A N/A | Magenta Therapeutics Inc. | MGTA | Beetham Thomas W. See Remarks | 20,000 | $0 | 20,000 (Direct) | View |
| 2021-06-14 Option Award | 2021-06-15 4:33 pm | N/A 2031-06-13 | Magenta Therapeutics Inc. | MGTA | Beetham Thomas W. See Remarks | 200,000 | $0 | 200,000 (Direct) | View |
Ownership | 2021-06-15 4:29 pm | N/A N/A | Magenta Therapeutics Inc. | MGTA | Beetham Thomas W. See Remarks | 0 | $0 | 0 (Direct) | View |
| 2021-03-20 Option Award | 2021-03-23 5:32 pm | N/A N/A | Kiniksa Pharmaceuticals Ltd. | KNSA | Beetham Thomas W. EVP & Chief Legal Officer | 10,142 | $0 | 10,142 (Direct) | View |
| 2021-03-16 Option Award | 2021-03-18 7:07 pm | N/A 2031-03-15 | Kiniksa Pharmaceuticals Ltd. | KNSA | Beetham Thomas W. EVP & Chief Legal Officer | 61,380 | $0 | 61,380 (Direct) | View |
| 2021-02-03 Conversion | 2021-02-05 6:55 pm | N/A N/A | Kiniksa Pharmaceuticals Ltd. | KNSA | Beetham Thomas W. EVP & Chief Legal Officer | 300,000 | $0 | 411,680 (Direct) | View |
| 2020-09-10 Option Award | 2020-09-14 5:14 pm | N/A 2030-09-09 | Kiniksa Pharmaceuticals Ltd. | KNSA | Beetham Thomas W. EVP & Chief Legal Officer | 75,000 | $0 | 75,000 (Direct) | View |